Volume 20, Number 11—November 2014
Resolution Threshold of Current Molecular Epidemiology of Diphtheria
“The fox who longed for grapes, beholds with pain
The tempting clusters were too high to gain;
Grieved in his heart he forced a careless smile,
And cried, ‘They’re sharp and hardly worth my while.”
(Aphra Behn, 1687, after Aesop’s The Fox and the Grapes)
To the Editor: Diphtheria is an extremely rare disease in Europe but remains a major health issue in developing countries (1–3). In recent years, steady progress has been made toward understanding the factors of pathogenicity of its causative agent (Corynebacterium diphtheriae). In contrast, remarkable advances in its basic genomics have not been sufficiently translated into the molecular epidemiology of diphtheria. A recent report by Zasada (4) offers an apt opportunity to take a new look at this issue.
The current genotyping repertoire of C. diphtheriae includes several methods but those most frequently used are classical ribotyping and pulsed-field gel electrophoresis (PFGE). More recently, a multilocus sequence typing (MLST) scheme for C. diphtheriae was developed (5). Compared with ribotyping, PFGE, and other methods based on analysis of banding profiles, MLST results are digital, unambiguous, and portable. MLST discrimination of 150 isolates from 18 countries and spanning 50 years was “in accordance with previous ribotyping data, and clonal complexes associated with disease outbreaks were clearly identified by MLST” (5).
In the report by Zasada (4), all 3 recommended methods (PFGE, MLST, and ribotyping) were used to genotype 25 nontoxigenic C. diphtheriae isolates from Poland. The author concluded that these isolates “represent a single clone despite isolation … in different part of the country over a 9-year period” and raised the question of whether a single clone of C. diphtheriae is circulating in Poland (4). These isolates are related genetically, but do they represent a truly single clone or might they be further discriminated? Their circulation in Poland may be caused by their high pathogenicity, but also (or instead) it might reflect their endemic, historical prevalence in this country. I believe that these questions are unlikely to be answered by the internationally agreed-upon methods for C. diphtheriae typing because of their insufficient resolution: the discriminatory power of MLST does not exceed to that of ribotyping (5).
Two in silico–inspired approaches have recently been pursued toward more precise molecular genetics and epidemiology of diphtheria. The first approach is based on whole-genome sequencing (WGS). After years of stagnation, the number of complete C. diphtheriae genomes has finally started to increase: currently 13 complete and 3 draft genomes are available in GenBank (as of April 14, 2014). The second approach is locus oriented and makes use of the repetitive DNA sequences, namely, variable number tandem repeats (VNTR) and clustered, regularly interspaced short palindromic repeats (CRISPR) loci.
A study in Poland showed a discriminatory capacity of some of the VNTR loci in C. diphtheriae (6), although preliminary results were not compared with those from other typing methods. CRISPR loci in C. diphtheriae have been studied in more detail and CRISPR-based spoligotyping showed a high level of discrimination for an epidemic clone in Russia and Belarus (7,8). In particular, 156 isolates from Russia of the epidemic clone (classical ribotypes Sankt-Petersburg and Rossija) were subdivided into 45 spoligotypes (7).
Further studies underlined the limitations of CRISPR-based typing: the 3 described CRISPR loci are not present simultaneously in all isolates; and most strains have unique spacers at the leader part of the array, which indicates their independent evolution after they diverged from a common ancestor (9). Accordingly, Sangal et al. suggested that CRISPR-based typing might not necessarily provide information on evolutionary relationships between different strains, but it might offer a high level of discrimination to study local epidemiology (9).
Recent advances in C. diphtheriae genomics concern an increasing number of complete genomes in GenBank, development of new ideas (e.g., revisiting biochemical subdivision into biovars) (10), and development of new typing schemes (MLST, VNTR, and spoligotyping). Nevertheless, in spite of lack of genetic support, biochemical classification into biovars is still uncritically used. In spite of other demonstrated or potential tools (e.g., CRISPR, VNTR), classical or new methods (all with limited resolution) are still used in many studies, both global and local. In spite of many available complete genomes, this wealth of information has not been translated into a WGS-informed high-resolution typing scheme. It might be sufficient to sequence all 3 CRISPR/cas loci in all strains studied by Zasada (4) to gain some insight into their relatedness and possible spatiotemporal evolution. A phylogenetically more robust, albeit more expensive, solution would be using WGS analysis to achieve the same objective.
In conclusion, molecular epidemiology of diphtheria would definitely benefit from implementation of more precise molecular genetics. First, WGS (or at least core genome) analysis might offer a broader range of possible general solutions from global tracing of large clonal clusters (current threshold) toward fine-tuned strain discrimination. At the same time, a multicenter evaluation of recently developed inexpensive and discriminatory VNTR and CRISPR methods is warranted to see if and how they could complement regional surveillance.
I thank 4 anonymous reviewers for providing useful and contrasting comments.
- Wagner KS, White JM, Lucenko I, Mercer D, Crowcroft NS, Neal S, ; Diphtheria Surveillance Network. Diphtheria in the postepidemic period, Europe, 2000–2009. Emerg Infect Dis. 2012;18:217–25. DOIPubMedGoogle Scholar
- Viguetti SZ, Pacheco LG, Santos LS, Soares SC, Bolt F, Baldwin A, Multilocus sequence types of invasive Corynebacterium diphtheriae isolated in the Rio de Janeiro urban area, Brazil. Epidemiol Infect. 2012;140:617–20 . DOIPubMedGoogle Scholar
- Meera M, Rajarao M. Diphtheria in Andhra Pradesh—a clinical-epidemiological study. Int J Infect Dis. 2014;19:74–8. DOIPubMedGoogle Scholar
- Zasada AA. Nontoxigenic highly pathogenic clone of Corynebacterium diphtheriae, Poland, 2004–2012. Emerg Infect Dis. 2013;19:1870–2 . DOIPubMedGoogle Scholar
- Bolt F, Cassiday P, Tondella ML, Dezoysa A, Efstratiou A, Sing A, Multilocus sequence typing identifies evidence for recombination and two distinct lineages of Corynebacterium diphtheriae. J Clin Microbiol. 2010;48:4177–85 . DOIPubMedGoogle Scholar
- Zasada AA, Jagielski M, Rzeczkowska M, Januszkiewicz A. The use of MLVA for Corynebacterium diphtheriae genotyping—preliminary studies [in Polish]. Med Dosw Mikrobiol. 2011;63:209–18 .PubMedGoogle Scholar
- Mokrousov I, Limeschenko E, Vyazovaya A, Narvskaya O. Corynebacterium diphtheriae spoligotyping based on combined use of two CRISPR loci. Biotechnol J. 2007;2:901–6 . DOIPubMedGoogle Scholar
- Mokrousov I, Vyazovaya A, Kolodkina V, Limeschenko E, Titov L, Narvskaya O. Novel macroarray-based method of Corynebacterium diphtheriae genotyping: evaluation in a field study in Belarus. Eur J Clin Microbiol Infect Dis. 2009;28:701–3. DOIPubMedGoogle Scholar
- Sangal V, Fineran PC, Hoskisson PA. Novel configurations of type I and II CRISPR-Cas systems in Corynebacterium diphtheriae. Microbiology. 2013;159:2118–26 . DOIPubMedGoogle Scholar
- Sangal V, Burkovski A, Hunt AC, Edwards B, Blom J, Hoskisson PA. A lack of genetic basis for biovar differentiation in clinically important Corynebacterium diphtheriae from whole genome sequencing. Infect Genet Evol. 2014;21:54–7 . DOIPubMedGoogle Scholar
Table of Contents – Volume 20, Number 11—November 2014
|EID Search Options|
|Advanced Article Search – Search articles by author and/or keyword.|
|Articles by Country Search – Search articles by the topic country.|
|Article Type Search – Search articles by article type and issue.|
Please use the form below to submit correspondence to the authors or contact them at the following address:
Igor Mokrousov, Laboratory of Molecular Microbiology, St. Petersburg Pasteur Institute, St. Petersburg, Russia